Profile
| Metric | Value |
|---|---|
| Full Name | Evotec SE |
| Ticker | NASDAQ: EVO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Germany |
| IPO | |
| Indexes | Not included |
| Website | evotec.com |
| Employees | 4,766 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $3.63 | |
| Price, 1D Change | +8.36% | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.71 | |
| Revenue | $862M | |
| Revenue, 1Y Change | +2.04% | |
| EPS | -$0.60 | |
| EPS, 1Y Change | -133.27% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 4:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | EVTC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.60 | |
| EPS Estimate | N/A | -$0.66 |
| EPS Est. Change | N/A | -10.90% |
| Revenue | $862.07M | |
| Revenue Estimate | N/A | $781.18M |
| Revenue Est. Change | N/A | -9.38% |
| Current Price | $3.63 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.35 | -$0.26 | +26.74% | |
| -$0.90 | -$0.60 | +33.54% | |
| -$0.66 | N/A | -10.90% | |
| -$0.36 | N/A | +39.81% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $816.87M | $844.81M | +3.42% | |
| $797.01M | $862.07M | +8.16% | |
| $781.18M | N/A | -9.38% | |
| $839.70M | N/A | -2.60% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -15.78% | |
| Price, 3Y | -57.39% | |
| Market Cap, 1Y | -15.68% | |
| Market Cap, 3Y | -57.20% | |
| Revenue, 1Y | +2.04% | |
| Revenue, 3Y | +18.01% | |
| EPS, 1Y | -133.27% | |
| EPS, 3Y | -178.48% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $3.63 | |
| SMA 200 | $3.70 | |
| SMA 200 vs Price | +1.89% | |
| SMA 50 | $3.24 | |
| SMA 50 vs Price | -10.75% | |
| Beta | 0.71 | |
| ATR | $0.12 | |
| 14-Day RSI | 71.79 | |
| 10-Day Volatility | 51.69% | |
| 1-Year Volatility | 55.12% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $862.07M | |
| EPS | -$0.60 | |
| Gross Profit | $71.24M | |
| Gross Margin | 8.26% | |
| Operating Profit | -$185.01M | |
| Operating Margin | -21.46% | |
| Net Income | -$212.10M | |
| Net Margin | -24.60% | |
| EBITDA | -$75.09M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.47 | |
| Current Ratio | 1.98 | |
| Quick Ratio | 1.89 | |
| - | ||
| F-Score | 4 | |
| Altman Z-Score | 0.57 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 1.55 | |
| PB Ratio | 1.37 | |
| EV/EBITDA | -28.91 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $986.34M | |
| Cash & Equivalents | $410.89M | |
| Total Assets | $2.07B | |
| Current Assets | $706.17M | |
| Total Liabilities | $1.08B | |
| Current Liabilities | $356.82M | |
| Total Debt | $459.28M | |
| Short Term Debt | $52.60M | |
| Accounts Payable | $88.84M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.07B | |
| Operating Expenses | $256.25M | |
| Cost Of Goods Sold | $790.83M | |
| SG&A | $0.00 | |
| D&A | $109.92M | |
| Interest Expense | $0.00 | |
| Income Tax | -$48.42M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $19.41M | |
| CFI | -$83.11M | |
| CFF | -$168.20M | |
| Capex | $143.04M | |
| Free Cash Flow | -$123.63M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Morgan Stanley | → | |
| B of A Securities | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with EVO
Data Sources & References
- EVO Official Website www.evotec.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1412558/000110465925035638/0001104659-25-035638-index.htm
- EVO Profile on Yahoo Finance finance.yahoo.com/quote/EVO
- EVO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/evo
FAQ
What is the ticker symbol for Evotec SE?
The ticker symbol for Evotec SE is NASDAQ:EVO
Does Evotec SE pay dividends?
No, Evotec SE does not pay dividends
What sector is Evotec SE in?
Evotec SE is in the Healthcare sector
What industry is Evotec SE in?
Evotec SE is in the Specialty & Generic Drug Manufacturers industry
What country is Evotec SE based in?
Evotec SE is headquartered in Germany
When did Evotec SE go public?
Evotec SE initial public offering (IPO) was on February 5, 2004
Is Evotec SE in the S&P 500?
No, Evotec SE is not included in the S&P 500 index
Is Evotec SE in the NASDAQ 100?
No, Evotec SE is not included in the NASDAQ 100 index
Is Evotec SE in the Dow Jones?
No, Evotec SE is not included in the Dow Jones index
When was Evotec SE last earnings report?
Evotec SE's most recent earnings report was on August 14, 2025
When does Evotec SE report earnings?
The date for Evotec SE's next earnings report has not been announced yet
